Premium Transparency Act
Summary
The Premium Transparency Act (HR9397), introduced June 23, 2026, requires health insurers to publish overhead cost and claim payment percentages starting in 2027. At the early committee-referral stage with no funding attached, the bill imposes minor compliance costs on major insurers like $UNH, $CI, $HUM, and $ELV but does not alter revenue drivers. Market impact is negligible at this procedural phase.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.The bill only mandates disclosure of overhead and retained premium percentages—it does not change medical loss ratio (MLR) requirements or price controls.
- 2.At the early committee-referral stage, the bill has low probability of enactment without Senate companion or administration backing.
- 3.Compliance costs for major insurers are negligible (estimated $1-5M annually) and will not materially affect earnings or stock performance.
Market Implications
No immediate market implications are expected from this bill. Health insurer stocks remain driven by membership growth, medical cost trend (MLR), and Medicare/Medicaid policy changes. The transparency requirement, if enacted, would not alter underlying business dynamics. Investors should focus on earnings season and CMS rate notices for real signals.
Full Analysis
What Happened: On June 23, 2026, Rep. Pfluger (R-TX-11) introduced H.R. 9397, the Premium Transparency Act, which was referred to both the Energy and Commerce and Ways and Means Committees. The bill amends Section 2718 of the Public Health Service Act to require health insurers to publicly report the percentage of premium revenue spent on overhead categories and the percentage retained by the insurer. The requirement applies to all group and individual health plans (including grandfathered) for plan years beginning on or after January 1, 2027.
Money Trail: The bill does not authorize or appropriate any federal funds. The only financial impact is the compliance cost for insurers to compile, format, and publish the required data. This is a regulatory reporting mandate, not a spending program.
Convergence: No related legislative signals, procurements, or executive actions were provided. This bill stands alone as a transparency measure without a broader administration push or companion bill in the Senate. As a result, convergence is absent.
Structural Winners and Losers: The primary 'losers' are health insurers that will incur administrative costs. However, for large publicly traded insurers—UnitedHealth Group, Cigna ($CI), Humana ($HUM), Elevance Health ($ELV)—these costs are immaterial relative to their scale (sub-$5M annually vs. $100B+ revenues). Smaller insurers or nonprofit Blue Cross plans may face a proportionally higher burden but are largely private. No sector benefits directly. The bill could indirectly pressure insurers with high overhead ratios to justify them, but no enforcement mechanism or penalty is attached.
Timeline: The bill is at an early stage. It must pass both House committees, then the full House, then the Senate, and be signed by the President. Given the 119th Congress is midway through its 2nd session, the likelihood of enactment in its current form is low, especially without a Senate companion. No further actions have occurred since introduction.
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
No confirming evidence found yet from contracts, insider trades, or congressional activity
What the bill does
Mandatory public disclosure of overhead cost percentage and retained premium percentage for group/individual health plans, beginning plan year 2027.
Who must act
Health insurance issuers offering group or individual health insurance coverage (including grandfathered plans) in the US.
What happens
Increased administrative costs for data compilation, formatting, and publication; potential reputational pressure if overhead ratios exceed competitor or public expectations.
Stock impact
Cigna's US Commercial and International Health segments (~$120B revenue) incur minor compliance costs (~$1-3M annually). Transparency may slightly affect Cigna's managed care reputation but no material revenue shift.
What the bill does
Mandatory public disclosure of overhead cost percentage and retained premium percentage for group/individual health plans, beginning plan year 2027.
Who must act
Health insurance issuers offering group or individual health insurance coverage (including grandfathered plans) in the US.
What happens
Increased administrative costs for data compilation, formatting, and publication; potential reputational pressure if overhead ratios exceed competitor or public expectations.
Stock impact
Humana's individual and group Medicare Advantage and commercial segments (~$100B revenue) bear small compliance costs (~$1-3M). Overhead transparency could spotlight Humana's lower margins vs peers, but no immediate business effect.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
To amend title XVIII of the Social Security Act to require the inclusion of certain information in Medicare Advantage encounter data.
To amend the Employee Retirement Income Security Act of 1974 to increase transparency of group health plan data, prevent discrimination, and for other purposes.
To amend title XXVII of the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to require the displaying of claim denial rates.
To amend the Patient Protection and Affordable Care Act to provide that qualified health plans are not required to use a provider network.
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries
This executive order directs the CDC and ACIP to review and potentially update the U.S. childhood vaccine schedule to align with recommendations from peer developed countries, which recommend fewer vaccines. It maintains insurance coverage for all currently available vaccines without cost sharing and emphasizes protecting religious liberty and parental authority.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →